News NHS drug deal could fund vital cystic fibrosis research - Ve... Vertex wants long-term funding for CF research
News Call for new restrictions on UK vaccine prices Proposals also include fresh attack on drug prices
News Eisai disappointed after NICE rejects earlier use for breast... NICE says no to Halaven in second line breast cancer
News Vertex negotiating with NHS England on cystic fibrosis drug ... Vertex is trying reach a deal with NHS England to give patients access to all its approved cystic fibrosis (CF) drugs - and hopes it could also fund further drugs in the pipeline.
News NICE recommends funding for three thyroid cancer drugs Eisai's drug finally funded after two year delay
News GBL joins CVC in €10.7bn takeover bid for Recordati A consortium of investors has made a €10.7bn offer to take Italian pharma Recordati private, but some analysts are sceptical the deal will go through.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
